PURPOSE: To evaluate pregnancy rate (PR) and live birth rate (LBR) after freezing pronuclear (PN) embryos for two purposes: to reduce the risk of ovarian hyperstimulation syndrome (OHSS) and to bank embryos for cancer patients anticipating gametotoxic chemotherapy/radiotherapy. METHODS: Data from 3,621 consecutive IVF cycles were retrospectively analyzed. PN freezing was offered to patients at risk for OHSS and for those wishing to preserve fertility prior to cancer therapy. Primary outcomes evaluated were PR and LBR. Outcomes were compared to patients who underwent fresh embryo transfer (ET) in 2006. RESULTS: Sixty-six patients froze PN embryos. Thirty-eight were at risk for OHSS. The LBR was 34.3% after one transfer, and 51.4% after a mean of 1.4 transfers. Twenty-eight cancer patients froze embryos. The LBR was 16.7% after one transfer and 25.0% after a mean of 1.5 transfers. The LBR was 35.5% for patients who underwent fresh ET. CONCLUSION: PN freezing with delayed ET is an effective tool for achieving pregnancy for patients at risk of OHSS and for cancer patients wishing to preserve fertility.
PURPOSE: To evaluate pregnancy rate (PR) and live birth rate (LBR) after freezing pronuclear (PN) embryos for two purposes: to reduce the risk of ovarian hyperstimulation syndrome (OHSS) and to bank embryos for cancerpatients anticipating gametotoxic chemotherapy/radiotherapy. METHODS: Data from 3,621 consecutive IVF cycles were retrospectively analyzed. PN freezing was offered to patients at risk for OHSS and for those wishing to preserve fertility prior to cancer therapy. Primary outcomes evaluated were PR and LBR. Outcomes were compared to patients who underwent fresh embryo transfer (ET) in 2006. RESULTS: Sixty-six patients froze PN embryos. Thirty-eight were at risk for OHSS. The LBR was 34.3% after one transfer, and 51.4% after a mean of 1.4 transfers. Twenty-eight cancerpatients froze embryos. The LBR was 16.7% after one transfer and 25.0% after a mean of 1.5 transfers. The LBR was 35.5% for patients who underwent fresh ET. CONCLUSION: PN freezing with delayed ET is an effective tool for achieving pregnancy for patients at risk of OHSS and for cancerpatients wishing to preserve fertility.
Authors: J Donnez; M M Dolmans; D Demylle; P Jadoul; C Pirard; J Squifflet; B Martinez-Madrid; A van Langendonckt Journal: Lancet Date: 2004 Oct 16-22 Impact factor: 79.321
Authors: Puja S Gera; Laura L Tatpati; Michael C Allemand; Mark A Wentworth; Charles C Coddington Journal: Fertil Steril Date: 2009-04-07 Impact factor: 7.329
Authors: J Testart; B Lassalle; J Belaisch-Allart; A Hazout; R Forman; J D Rainhorn; R Frydman Journal: Fertil Steril Date: 1986-08 Impact factor: 7.329
Authors: Eric Scott Sills; Laura J McLoughlin; Marc G Genton; David J Walsh; Graham D Coull; Anthony P H Walsh Journal: J Ovarian Res Date: 2008-11-06 Impact factor: 4.234
Authors: Eden R Cardozo; Alexcis P Thomson; Anatte E Karmon; Kristy A Dickinson; Diane L Wright; Mary E Sabatini Journal: J Assist Reprod Genet Date: 2015-01-18 Impact factor: 3.412
Authors: M E Elena Ter Welle-Butalid; I J H Ingeborg Vriens; J G Josien Derhaag; E M Edward Leter; C E Christine de Die-Smulders; M Marjolein Smidt; R J T Ron van Golde; V C G Vivianne Tjan-Heijnen Journal: J Assist Reprod Genet Date: 2019-11-23 Impact factor: 3.412
Authors: Charlotte Sonigo; Nelly Frydman; Anne Mayeur; Vincent Puy; Victoria Windal; Laetitia Hesters; Vanessa Gallot; Alexandra Benoit; Michael Grynberg Journal: J Assist Reprod Genet Date: 2021-04-01 Impact factor: 3.357